InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Albanna Amro A., Chairman & CEO. Officer active across 2 companies, notably Aditx Therapeutics, Inc.. Cumulatively, 5 reports have been published. Split: 3 buys · 0 sell. Total volume traded: €22k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 19 July 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Amro A. Albanna is the Chairman and CEO of Aditx Therapeutics, Inc. He leads the company by defining the strategic vision and overseeing all operations. His role includes managing human resources, business development, and communication with shareholders. Through his leadership, he ensures that the company remains competitive in the market and meets the needs of its clients while achieving its financial objectives.